共 50 条
- [1] MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes [J]. JOURNAL OF IMMUNOLOGY, 1998, 160 (02): : 661 - 666
- [3] Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules [J]. JOURNAL OF IMMUNOLOGY, 1996, 156 (10): : 3821 - 3827
- [5] γδ T cells present antigen to CD4+ αβ T cells [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (06) : 707 - 714
- [7] Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are the predominant antigen presenting cells in vivo [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (10): : 5451 - 5461
- [8] Tumor cells present MHC class II-restricted nuclear and mitochondrial antigens and are predominant antigen presenting cells in vivo [J]. FASEB JOURNAL, 2001, 15 (05): : A1022 - A1022
- [10] Activated CD4+ T Cells Dramatically Enhance Chemotherapeutic Tumor Responses In Vitro and In Vivo [J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (10): : 6800 - 6807